We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$933M
AUM Growth
+$17.2M
Cap. Flow
+$4.21M
Cap. Flow %
0.45%
Top 10 Hldgs %
32.72%
Holding
112
New
29
Increased
12
Reduced
26
Closed
30

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$20.8M
2
HUM icon
Humana
HUM
+$20.5M
3
THC icon
Tenet Healthcare
THC
+$16.9M
4
GE icon
GE Aerospace
GE
+$13.2M
5
ARMK icon
Aramark
ARMK
+$13M

Sector Composition

Rank Sector Weight
1 Healthcare 24.32%
2 Industrials 16.59%
3 Technology 10.07%
4 Consumer Staples 5%
5 Consumer Discretionary 4.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MU icon
101
Micron Technology
MU
$996B
-72,500
Closed -$8.55M
NEE icon
102
CALL
NextEra Energy
NEE
$176B
-300,000
Closed -$19.2M
NEE icon
103
NextEra Energy
NEE
$176B
-110,000
Closed -$7.03M
NTES icon
104
NetEase
NTES
$83.5B
-85,000
Closed -$8.79M
RNR icon
105
RenaissanceRe
RNR
$13.4B
-30,000
Closed -$7.05M
SHW icon
106
Sherwin-Williams
SHW
$88.2B
-60,029
Closed -$20.8M
TAN icon
107
PUT
Invesco Solar ETF
TAN
$1.45B
-100,000
Closed -$4.54M
TCOM icon
108
Trip.com Group
TCOM
$29.1B
-255,000
Closed -$11.2M
UNP icon
109
Union Pacific
UNP
$175B
-43,650
Closed -$10.7M
VNT icon
110
Vontier
VNT
$4.97B
-200,000
Closed -$9.07M
VST icon
111
CALL
Vistra
VST
$47.7B
-225,000
Closed -$15.7M
VINC
112
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
-19,250
Closed -$1.95M

Similar funds

Kingdon Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Kingdon Capital Management held 112 positions worth $933M, up 1.9% from $916M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Kingdon Capital Management's Q2 2024 filing shows 29 new, 12 increased, 26 reduced and 30 closed positions. Its largest new stake was UnitedHealth: 39,700 shares worth $20.2M. The largest sale was Sherwin-Williams, an estimated $20.8M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 21% a quarter earlier, followed by Industrials and Technology.

  • Kingdon Capital Management's largest Q2 2024 buy was UnitedHealth: 39,700 shares worth $20.2M.
  • Kingdon Capital Management added most to Cytokinetics in Q2 2024, an estimated $9.1M increase.
  • Kingdon Capital Management's biggest Q2 2024 reduction was Tenet Healthcare, cutting an estimated $16.9M.
  • Kingdon Capital Management fully exited Sherwin-Williams in Q2 2024, selling an estimated $20.8M.
  • Kingdon Capital Management's ten largest holdings make up 33% of its $933M portfolio in Q2 2024.
  • Kingdon Capital Management opened 29 new positions and closed 30 in Q2 2024.
  • Kingdon Capital Management's portfolio value rose 1.9% quarter-over-quarter to $933M.

Based on Kingdon Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.